Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Siepler

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|January 1, 1986
A dosage alternative for H2-receptor antagonists--constant infusionJ K Siepler
The New England Journal of Medicine|January 13, 1977
Intravenous phenytoinJ L Bauman, J K Siepler
American Journal of Hospital Pharmacy|January 1, 1978
Phenytoin crystallization in intravenous fluidsJ L Bauman, J K Siepler
American Journal of Hospital Pharmacy|April 1, 1982
Crystallization of three phenytoin preparations in intravenous solutionsN Giacona, J L Bauman, J K Siepler
Clinical Pharmacy|February 1, 1986
Current concepts in clinical therapeutics: peptic ulcer diseaseJ K Siepler, K Mahakian, W T Trudeau
Clinical Pharmacy|June 1, 1990
Selecting drug therapy for patients with duodenal ulcersJ K Siepler, R M Mowers, W L Trudeau
DICP : the Annals of Pharmacotherapy|October 1, 1989
Use of continuous infusion of histamine2-receptor antagonists in critically ill patientsJ K Siepler, W Trudeau, D E Petty
IMJ. Illinois Medical Journal|April 1, 1978
Treatment with H2 receptor antagonists. Zollinger-Ellison SyndromeJ K Siepler, P Donahue, K Campagna, et al.
The New England Journal of Medicine|July 10, 1980
Cimetidine for prevention of acute gastrointestinal bleedingJ K Siepler, P E Donahue, C T Bombeck
Clinical Pharmacy|November 1, 1982
Ranitidine: a new H2-receptor antagonistB D Berner, C S Conner, D R Sawyer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|January 1, 1986
A dosage alternative for H2-receptor antagonists--constant infusionJ K Siepler
The New England Journal of Medicine|January 13, 1977
Intravenous phenytoinJ L Bauman, J K Siepler
American Journal of Hospital Pharmacy|January 1, 1978
Phenytoin crystallization in intravenous fluidsJ L Bauman, J K Siepler
American Journal of Hospital Pharmacy|April 1, 1982
Crystallization of three phenytoin preparations in intravenous solutionsN Giacona, J L Bauman, J K Siepler
Clinical Pharmacy|February 1, 1986
Current concepts in clinical therapeutics: peptic ulcer diseaseJ K Siepler, K Mahakian, W T Trudeau
Clinical Pharmacy|June 1, 1990
Selecting drug therapy for patients with duodenal ulcersJ K Siepler, R M Mowers, W L Trudeau
DICP : the Annals of Pharmacotherapy|October 1, 1989
Use of continuous infusion of histamine2-receptor antagonists in critically ill patientsJ K Siepler, W Trudeau, D E Petty
IMJ. Illinois Medical Journal|April 1, 1978
Treatment with H2 receptor antagonists. Zollinger-Ellison SyndromeJ K Siepler, P Donahue, K Campagna, et al.
The New England Journal of Medicine|July 10, 1980
Cimetidine for prevention of acute gastrointestinal bleedingJ K Siepler, P E Donahue, C T Bombeck
Clinical Pharmacy|November 1, 1982
Ranitidine: a new H2-receptor antagonistB D Berner, C S Conner, D R Sawyer, et al.
Pageof 2